Evidence map›Paper›PMID 41484743›Full record

ArticleApplied biochemistry and biotechnology2026

Circ_0039857: A Key Player in Combating Immune Disorders and Ferroptosis in High-Glucose-induced HK-2 Cells and Diabetic Kidney Disease Mice.

Xun Sun, Ye Xiao, Haiyan Chi, Li Liu, Huaxiao Tang, Jianjun Dong

Abstract read
PubMed Publisher
In one paragraph

Article in Applied biochemistry and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Xun SunDepartment of Endocrinology, Qilu Hospital of Shandong University, No. 107 Wenhua West Road, Shandong, Jinan City, 250012, China.
Ye XiaoDepartment of Clinical Laboratory, Weihai Municipal Second Hospital Affiliated to Qingdao University, Shandong, Weihai City, 264299, China.
Haiyan ChiDepartment of Endocrinology, Weihai Municipal Hospital, Shandong, Weihai City, 264299, China.
Li LiuDepartment of Ultrasound, Weihai Municipal Hospital, Shandong, Weihai City, 264299, China.
Huaxiao TangDepartment of Pathology, Weihai Municipal Second Hospital Affiliated to Qingdao University, Shandong, Weihai City, 264299, China.
Jianjun DongDepartment of Endocrinology, Qilu Hospital of Shandong University, No. 107 Wenhua West Road, Shandong, Jinan City, 250012, China. DongJianjun0374@21cn.com.

Funding

Shandong Provincial Medical and Health Science and Technology Project 202303060195
6 · The paper itself

Abstract

Diabetic kidney disease (DKD) is a microvascular complication associated with diabetes. Circ_0039857 has been shown to exert regulatory functions in various human diseases. This research aimed to elucidate the role and mechanism of circ_0039857 in DKD. Our findings revealed that both circ_0039857 and miR-4739 expressions were decreased in DKD, while PON1 levels were elevated. Functionally, circ_0039857 overexpression repressed immune disorders and ferroptosis in HG-induced HK-2 cells. Mechanistically, circ_000888 was bound to miR-4739, and miR-4739 was bound to PON1. Meanwhile, the effects of circ_0039857 overexpression on immune disorder and ferroptosis in HG-induced HK-2 cells were abolished after miR-4739 mimic or si-PON1 co-transfection, revealing the key regulatory function of circ_0039857/miR-4739/PON1 axis in DKD. Furthermore, circ_0039857 repressed DKD progression in vivo, mainly by reducing the proliferation of renal mesangial cells and renal collagen deposition in DKD mice. Also, circ_0039857 reduced immune disorders and ferroptosis in in vivo model of DKD. In summary, circ_0039857 overexpression inhibited immune disorders and ferroptosis by targeting miR-4739/PON1, thus alleviating DKD.

Indexed as

Diabetic NephropathiesFerroptosisGlucoseRNA, CircularAnimalsCell LineHumansMaleMiceMicroRNAsGlucoseMicroRNAsRNA, CircularCirc_0039857Diabetic kidney diseaseMiR-4739PON1

Identifiers

PMID41484743

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.